These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 29493071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
    Fusade T.
    Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
    [Abstract] [Full Text] [Related]

  • 4. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
    Heng JK, Chua SH, Goh CL, Cheng S, Tan V, Tan WP.
    J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of xanthelasma palpebrarum with a combination of radiofrequency ablation and wound suturing.
    Singh A, Tiwary PK, Jha AK, Zeeshan M, Ranjan A.
    J Cosmet Dermatol; 2020 Dec; 19(12):3286-3290. PubMed ID: 33459474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser.
    Park EJ, Youn SH, Cho EB, Lee GS, Hann SK, Kim KH, Kim KJ.
    Dermatol Surg; 2011 Jun; 37(6):791-6. PubMed ID: 21605240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum.
    Basar E, Oguz H, Ozdemir H, Ozkan S, Uslu H.
    Int Ophthalmol; 2004 Jan; 25(1):9-11. PubMed ID: 15085969
    [Abstract] [Full Text] [Related]

  • 17. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum.
    Mourad B, Elgarhy LH, Ellakkawy HA, Elmahdy N.
    J Cosmet Dermatol; 2015 Sep; 14(3):209-15. PubMed ID: 26251333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Xanthelasma palpebrarum: treatment with the erbium:YAG laser.
    Borelli C, Kaudewitz P.
    Lasers Surg Med; 2001 Sep; 29(3):260-4. PubMed ID: 11573229
    [Abstract] [Full Text] [Related]

  • 20. Ultrapulsed CO2 ablation in the treatment of xanthelasma palpebrarum: high satisfaction treatment with low recurrence.
    Al-Niaimi F.
    J Dermatolog Treat; 2022 Mar; 33(2):1116-1118. PubMed ID: 32485119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.